Clinical trials
Withdrawn Carcinoma, Non-Small-Cell Lung trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2018 | 4 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 2 |
| University Health Network, Toronto | 2 |
| Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec | 1 |
| Lady Davis Institute | 1 |
| McMaster University | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
| Spectrum Pharmaceuticals, Inc | 1 |
| University of British Columbia | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 10 |
| Lung Neoplasms | 4 |
| Adenocarcinoma of Lung | 2 |
| Carcinoma, Renal Cell | 1 |
| Neoplasm Metastasis | 1 |
| Neoplasm, Residual | 1 |
| Neoplasms | 1 |
| Squamous Cell Carcinoma of Head and Neck | 1 |
| Urinary Retention | 1 |
| Urinary Tract Infections | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.